APGE news · APGE stock

AbbVie Q2 2026 earnings: profit forecast cut for Apogee deal

Yahoo Finance · Jul 31, 2026 · Apogee Therapeutics, Inc. Common Stock (APGE)

The drugmaker beat second-quarter estimates on strong immunology sales but lowered its full-year adjusted earnings outlook by 14 cents a share

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.